Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-000416

Pres and CEO gave up 9,125 shares (to pay taxes)

  • Pres and CEO acquired 27,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Manion Douglas J. · Pres and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-01 Exercise or conversion : show line 1 in the form +27,000 50,938 D
2024-01-01 Shares withheld for taxes : show line 2 in the form −9,125 $1.05 $9,581 41,813 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −27,000 81,000 D
Loading xslF345X05/doc4.xml…